Myeloproliferative Neoplasms: Symptoms, Complications, and When to Suspect
Myeloproliferative neoplasms (MPNs)—polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF)—are clonal hematopoietic stem cell disorders with overlapping features.
Common Symptoms (Cytokine-Mediated)
- Fatigue, weakness (often disproportionate to anemia)
- Night sweats, low-grade fever
- Weight loss, early satiety (splenomegaly)
- Pruritus (especially aquagenic—after bathing; classic for PV)
- Bone pain, gout (hyperuricemia)
Physical Findings
- Splenomegaly (PV, PMF; ET less common)
- Hepatomegaly (PMF, advanced PV)
- Ruddy complexion (PV)
- Erythromelalgia: burning, redness, warmth in extremities (ET, PV; platelet-mediated)
Major Complications
- Thrombosis: Arterial (MI, stroke, TIA) and venous (DVT, PE, Budd-Chiari, portal vein). Leading cause of morbidity/mortality.
- Hemorrhage: Acquired von Willebrand (extreme thrombocytosis), platelet dysfunction.
- Transformation: To AML (~5–10% PMF, 2–5% PV/ET at 10 yrs) or accelerated phase MF.
- Myelofibrosis progression: ET/PV → post-PV/ET MF.
Diagnostic Clues
- PV: Hb >16.5 (M), >16.0 (F) g/dL; JAK2 V617F >95%; low EPO.
- ET: Platelets >450×10⁹/L; JAK2 (50–60%), CALR (25–30%), MPL (3–5%).
- PMF: Anemia, teardrop cells, leukoerythroblastosis, fibrosis (reticulin/collagen), JAK2/CALR/MPL.
Risk-Stratified Management
Focus on thrombosis prevention: phlebotomy (PV), aspirin (most), cytoreduction (hydroxyurea, interferon, ruxolitinib for MF) per IPSET-thrombosis, DIPSS-plus scores.
Multidisciplinary care (hematology, cardiology, genetics) improves outcomes.
Blood Disorders - Related Articles
- Recognizing Calf Blood Clots After Surgery: Symptoms & Prevention
- Thalassemia: Understanding Symptoms, Diagnosis & Management
- Kayexalate (Sodium Polystyrene Sulfonate): Uses, Side Effects & Information
- Understanding and Managing Low Blood Pressure (Hypotension)
- Myelofibrosis Prognosis: Understanding Long-Term Outlook & Life Expectancy
- Vitamins for Improved Circulation: A Natural Approach
- Understanding and Managing Von Willebrand Disease (VWD)
